Aurora Fire Rescue is expanding its "Leave-Behind Narcan" program by providing nasal naloxone kits to individuals after responding to overdose calls.

The initiative aims to reduce fatal opioid overdoses by ensuring that victims or bystanders have immediate access to life-saving medication before emergency services arrive. By leaving kits on-site, the department seeks to bridge the gap between the onset of an overdose and the arrival of professional medical help.

The expansion follows a significant increase in emergency responses within Aurora, Colorado. In 2025, Aurora Fire Rescue responded to more than 300 suspected opioid-related overdoses [1]. This volume of calls highlighted the need for a more aggressive distribution strategy to combat the ongoing opioid crisis in the region.

Under the program, firefighters leave behind kits that contain one nasal naloxone spray [2]. This delivery method is designed for ease of use by non-medical personnel, allowing anyone present to administer the drug into the nasal cavity of an unconscious person.

Officials said the goal is to empower the community to act quickly. Because naloxone temporarily reverses the effects of opioids, the window for intervention is narrow, making the availability of the drug at the scene critical for survival.

This strategy shifts the role of the fire department from purely reactive emergency response to a proactive public health measure. By distributing the medication directly to the environments where overdoses occur, the city hopes to lower the overall mortality rate associated with synthetic opioids.

Aurora Fire Rescue responded to more than 300 suspected opioid-related overdoses in 2025.

The shift toward 'leave-behind' programs reflects a broader public health strategy in the U.S. to decentralize emergency medicine. By treating naloxone as a community resource rather than a restricted clinical tool, cities are attempting to reduce the death rate in areas where emergency response times may be too slow to prevent brain damage or death from respiratory failure.